Robin J. Larson

3.4k total citations · 1 hit paper
29 papers, 2.2k citations indexed

About

Robin J. Larson is a scholar working on Cardiology and Cardiovascular Medicine, General Health Professions and Epidemiology. According to data from OpenAlex, Robin J. Larson has authored 29 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 5 papers in General Health Professions and 5 papers in Epidemiology. Recurrent topics in Robin J. Larson's work include Venous Thromboembolism Diagnosis and Management (3 papers), Patient-Provider Communication in Healthcare (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Robin J. Larson is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (3 papers), Patient-Provider Communication in Healthcare (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Robin J. Larson collaborates with scholars based in United States, Tanzania and Egypt. Robin J. Larson's co-authors include Daniel Wiener, Renda Soylemez Wiener, Sarah Persing, Bruce E. Sands, Sadie M. Marden, Corey A. Siegel, Lisa M. Schwartz, Steven Woloshin, H. Gilbert Welch and Alexander J. Kallen and has published in prestigious journals such as JAMA, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Robin J. Larson

28 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Benefits and risks of tight glucose control in critically ill adults: a meta-analysis.

2008 702 citations Renda Soylemez Wiener, Daniel Wiener et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robin J. Larson United States	20	607	589	425	425	238	29	2.2k
Holly K. Van Houten United States	25	787 1.3×	299 0.5×	611 1.4×	245 0.6×	224 0.9×	75	2.4k
Nihal Thomas India	28	910 1.5×	391 0.7×	703 1.7×	449 1.1×	184 0.8×	241	3.0k
H. Allemand France	28	333 0.5×	525 0.9×	355 0.8×	256 0.6×	315 1.3×	88	2.1k
Martin Whyte United Kingdom	24	711 1.2×	321 0.5×	578 1.4×	224 0.5×	191 0.8×	133	2.4k
Aihua Bian United States	32	296 0.5×	351 0.6×	385 0.9×	141 0.3×	368 1.5×	86	2.8k
Eric Gerstenberger United States	19	347 0.6×	501 0.9×	143 0.3×	178 0.4×	108 0.5×	40	2.3k
J. L. Botha United Kingdom	21	895 1.5×	360 0.6×	342 0.8×	516 1.2×	159 0.7×	61	2.0k
Jamie P. Traynor United Kingdom	22	448 0.7×	213 0.4×	361 0.8×	232 0.5×	213 0.9×	69	2.0k
Sanjay Rampal Malaysia	31	700 1.2×	804 1.4×	355 0.8×	136 0.3×	532 2.2×	101	3.0k
Steen Ladelund Denmark	33	254 0.4×	876 1.5×	708 1.7×	272 0.6×	477 2.0×	107	3.6k

Countries citing papers authored by Robin J. Larson

Since Specialization

Citations

This map shows the geographic impact of Robin J. Larson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin J. Larson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin J. Larson more than expected).

Fields of papers citing papers by Robin J. Larson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin J. Larson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin J. Larson. The network helps show where Robin J. Larson may publish in the future.

Co-authorship network of co-authors of Robin J. Larson

This figure shows the co-authorship network connecting the top 25 collaborators of Robin J. Larson. A scholar is included among the top collaborators of Robin J. Larson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin J. Larson. Robin J. Larson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stein, Quinn, et al.. (2025). Role of Comprehensive Renal Genetic Testing in Diagnosing a RMND‐1 Mitochondrial Disease in Two Adult Cases Exhibiting Variable Disease Phenotypes. Clinical Case Reports. 13(4). e70421–e70421. 1 indexed citations

Larson, Robin J., et al.. (2024). Inactivated Poliovirus Vaccine Booster Reduces the Likelihood of COVID-19 Outcomes in Individuals Primed with Oral Poliovirus Vaccination. Vaccines. 12(3). 219–219. 1 indexed citations

Larson, Robin J., et al.. (2023). The Functional Implications of Broad Spectrum Bioactive Compounds Targeting RNA-Dependent RNA Polymerase (RdRp) in the Context of the COVID-19 Pandemic. Viruses. 15(12). 2316–2316. 2 indexed citations

Tosteson, Anna N.A., et al.. (2016). Surgery Versus Interferon Alpha-2b Treatment Strategies for Ocular Surface Squamous Neoplasia. Cornea. 35(5). 613–618. 31 indexed citations

Braga, Matthew S., et al.. (2015). Effect of just-in-time simulation training on provider performance and patient outcomes for clinical procedures: a systematic review. BMJ Simulation & Technology Enhanced Learning. 1(3). 94–102. 30 indexed citations

Newhall, Karina, Elizabeth C. Saunders, Robin J. Larson, David H. Stone, & Philip P. Goodney. (2015). Use of Protamine for Anticoagulation During Carotid Endarterectomy. JAMA Surgery. 151(3). 247–247. 20 indexed citations

Larson, Robin J., et al.. (2014). Cilostazol is associated with improved outcomes after peripheral endovascular interventions. Journal of Vascular Surgery. 59(6). 1607–1614. 28 indexed citations

Riblet, Natalie, Robin J. Larson, Bradley V. Watts, & Paul E. Holtzheimer. (2014). Reevaluating the role of antidepressants in cancer-related depression: a systematic review and meta-analysis. General Hospital Psychiatry. 36(5). 466–473. 27 indexed citations

Schpero, William L., et al.. (2013). Toxic effect of chemotherapy dosing using actual body weight in obese versus normal-weight patients: a systematic review and meta-analysis. Annals of Oncology. 24(12). 2952–2962. 63 indexed citations

10.

Taylor, Thomas H., et al.. (2012). Initiation of Allopurinol at First Medical Contact for Acute Attacks of Gout: A Randomized Clinical Trial. The American Journal of Medicine. 125(11). 1126–1134.e7. 73 indexed citations

11.

Larson, Robin J., et al.. (2010). Effectiveness of linezolid versus vancomycin treatment for MRSA skin and soft tissue infections. International Journal of Infectious Diseases. 14. e394–e394. 1 indexed citations

12.

Sheth, Siddharth & Robin J. Larson. (2010). The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials. BMC Infectious Diseases. 10(1). 183–183. 42 indexed citations

13.

Siegel, Corey A., Sadie M. Marden, Sarah Persing, Robin J. Larson, & Bruce E. Sands. (2009). Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis. Clinical Gastroenterology and Hepatology. 7(8). 874–881. 400 indexed citations

14.

Yilmaz, Taygan, et al.. (2009). Intravitreal Triamcinolone Acetonide Injection for Treatment of Refractory Diabetic Macular Edema. Ophthalmology. 116(5). 902–913. 95 indexed citations

15.

Wiener, Renda Soylemez, Daniel Wiener, & Robin J. Larson. (2008). Benefits and Risks of Tight Glucose Control in Critically Ill Adults. JAMA. 300(8). 933–933. 109 indexed citations

16.

MacKenzie, Todd A., et al.. (2007). Metabolic and hormonal effects of caffeine: randomized, double-blind, placebo-controlled crossover trial. Metabolism. 56(12). 1694–1698. 59 indexed citations

17.

Larson, Robin J. & H. Gilbert Welch. (2007). Risk for Increased Utilization and Adverse Health Outcomes among Men Served by the Veterans Health Administration. Military Medicine. 172(7). 690–696. 18 indexed citations

18.

Larson, Robin J., Steven Woloshin, Lisa M. Schwartz, & H. Gilbert Welch. (2005). Celebrity Endorsements of Cancer Screening. JNCI Journal of the National Cancer Institute. 97(9). 693–695. 63 indexed citations

19.

Kallen, Alexander J., Chad T. Wilson, & Robin J. Larson. (2005). Perioperative Intranasal Mupirocin for the Prevention of Surgical-Site Infections: Systematic Review of the Literature and Meta-Analysis. Infection Control and Hospital Epidemiology. 26(12). 916–922. 91 indexed citations

20.

Larson, Robin J. & Elliott S. Fisher. (2004). Should aspirin be continued in patients started on warfarin?. Journal of General Internal Medicine. 19(8). 879–886. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact